CORTISOL
Report
- Report Number
- 1823260-2016-00380
- Event Type
- Malfunction
- Date Received
- March 30, 2016
- Date of Event
- March 12, 2016
- Report Date
- April 26, 2016
- Manufacturer
- ROCHE DIAGNOSTICS
- Product Code
- NHG
- PMA / PMN Number
- K070788
- Removal / Correction Number
- NA
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
THIS EVENT OCCURRED IN (B)(6).
A SPECIFIC ROOT CAUSE COULD NOT BE IDENTIFIED. ADDITIONAL INFORMATION FOR FURTHER INVESTIGATION WAS REQUESTED BUT WAS NOT PROVIDED.BASED ON A REVIEW OF QUALITY CONTROL DATA, A GENERAL REAGENT ISSUE CAN BE EXCLUDED.
THE CUSTOMER COMPLAINED OF ERRONEOUS RESULTS FOR 1 PATIENT TESTED WITH BOTH CORTISOL AND CORTISOL II. THE CUSTOMER IS NOTICING A DIFFERENCE IN THE RESULTS BETWEEN THE 2 ASSAYS AND DOES NOT KNOW WHICH RESULT IS CORRECT. THE RESULTS FOR BOTH ASSAYS WERE REPORTED OUTSIDE OF THE LABORATORY. THE INITIAL CORTISOL RESULT WAS 5.87 NMOL/L. THE INITIAL CORTISOL II RESULT WAS 115.3 NMOL/L. THESE RESULTS WERE RUN ON E602 ANALYZER WITH SERIAL NUMBER (B)(4). THE SAMPLE WAS REPEATED AND THE CORTISOL RESULT WAS 4.80 NMOL/L. THE CORTISOL II RESULT WAS 109.7. THE CORTISOL RESULT WAS REPORTED OUTSIDE OF THE LABORATORY AS 5 NMOL/L AND THE CORTISOL II RESULT WAS REPORTED OUTSIDE OF THE LABORATORY AS 110 NMOL/L. THESE RESULTS WERE RUN ON E602 ANALYZER WITH SERIAL NUMBER (B)(4). THE CUSTOMER ALSO PROVIDED RESULTS FROM A PREVIOUS SAMPLE FROM THIS PATIENT OBTAINED ON AN UNKNOWN DATE AND THE CORTISOL RESULT WAS 9.0 NMOL/L. THE CORTISOL II RESULT WAS 114 NMOL/L. THE CUSTOMER BELIEVES THE ERRONEOUS RESULTS ARE DUE TO A PATIENT ANOMALY. NO ADVERSE EVENT OCCURRED. THE CORTISOL II ASSAY IS NOT SOLD IN THE UNITED STATES.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 192192 | CORTISOL | ENZYME IMMUNOASSAY, CORTISOL, SALIVARY | NHG | ROCHE DIAGNOSTICS | NA | 18538001 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |